Follow-The-Filings

LABT Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Biotherapeutics earnings company data as of 7:30 PM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS 0.65
Rev

SEC filings

Recent issuer filings from EDGAR · 21 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
424B3 PROSPECTUS SUPPLEMENT
10-Q QUARTERLY REPORT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 7.01,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
8-K 3.03,5.03,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
10-Q QUARTERLY REPORT
424B4 PROSPECTUS
S-1 REGISTRATION STATEMENT
424B3 PROSPECTUS SUPPLEMENT
8-K 5.02,9.01
424B4 PROSPECTUS
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT
S-1 REGISTRATION STATEMENT

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
3 Period Apr 24, 2026
4 Period Apr 24, 2026
3 Period Apr 17, 2026 · 3 forms

1 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice